Literature DB >> 24863917

Fabrication, characterization and bioevaluation of silibinin loaded chitosan nanoparticles.

Deep Pooja1, Dileep J Babu Bikkina1, Hitesh Kulhari2, Nalla Nikhila1, Srinivas Chinde3, Y M Raghavendra4, B Sreedhar5, Ashok K Tiwari6.   

Abstract

Silibinin is reported to possess multiple biological activities. However, its hydrophobic nature limits its bioavailability compromising in vivo biological activities. Nanoparticles-based delivery of such molecules has emerged as new technique to resolve these issues. Bio-degradable, compatible and adhesive nature of chitosan has recently attracted its suitability as a carrier for biologically active molecules. This study presents fabrication and characterization of chitosan-tripolyphosphate based encapsulation of silibinin. Various preparations of silibinin encapsulated chitosan-tripolyphosphate nanoparticles were studied for particle size, morphology, zeta-potential, and encapsulation efficiencies. Preparations were also evaluated for cytotoxic activities in vitro. The optimized silibinin loaded chitosan nanoparticles were of 263.7±4.1nm in particle size with zeta potential 37.4±1.57mV. Nanoparticles showed high silibinin encapsulation efficiencies (82.94±1.82%). No chemical interactions between silibinin and chitosan were observed in FTIR analysis. Powder X-ray diffraction analysis revealed transformed physical state of silibinin after encapsulation. Surface morphology and thermal behaviour were determined using TEM and DSC analysis. Encapsulated silibinin displayed increased dissolution and better cytotoxicity against human prostate cancer cells (DU145) than silibinin alone.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Characterization; Chitosan nanoparticles; Cytotoxicity; Dissolution; Silibinin

Mesh:

Substances:

Year:  2014        PMID: 24863917     DOI: 10.1016/j.ijbiomac.2014.05.035

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  7 in total

Review 1.  Emerging potential of natural products for targeting mucins for therapy against inflammation and cancer.

Authors:  Muzafar A Macha; Shiv Ram Krishn; Rahat Jahan; Kasturi Banerjee; Surinder K Batra; Maneesh Jain
Journal:  Cancer Treat Rev       Date:  2015-01-14       Impact factor: 12.111

2.  Green Synthesis of Silymarin-Chitosan Nanoparticles as a New Nano Formulation with Enhanced Anti-Fibrotic Effects against Liver Fibrosis.

Authors:  Abdullah Saad Abdullah; Ibrahim El Tantawy El Sayed; Abdel Moneim A El-Torgoman; Abul Kalam; S Wageh; Maher A Kamel
Journal:  Int J Mol Sci       Date:  2022-05-12       Impact factor: 6.208

Review 3.  Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.

Authors:  Hua Luo; Chi Teng Vong; Hanbin Chen; Yan Gao; Peng Lyu; Ling Qiu; Mingming Zhao; Qiao Liu; Zehua Cheng; Jian Zou; Peifen Yao; Caifang Gao; Jinchao Wei; Carolina Oi Lam Ung; Shengpeng Wang; Zhangfeng Zhong; Yitao Wang
Journal:  Chin Med       Date:  2019-11-06       Impact factor: 5.455

4.  Enhanced oral bioavailability and anticancer efficacy of fisetin by encapsulating as inclusion complex with HPβCD in polymeric nanoparticles.

Authors:  Amrita Kadari; Sagarika Gudem; Hitesh Kulhari; Murali Mohan Bhandi; Roshan M Borkar; Venkata Ramana Murthy Kolapalli; Ramakrishna Sistla
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

5.  Paclitaxel and quercetin nanoparticles co-loaded in microspheres to prolong retention time for pulmonary drug delivery.

Authors:  Kang Liu; Weijuan Chen; Tingting Yang; Baofang Wen; Dejun Ding; Michael Keidar; Jinbao Tang; Weifen Zhang
Journal:  Int J Nanomedicine       Date:  2017-11-13

Review 6.  Formulation Strategies for Enhancing the Bioavailability of Silymarin: The State of the Art.

Authors:  Alfonso Di Costanzo; Ruggero Angelico
Journal:  Molecules       Date:  2019-06-07       Impact factor: 4.411

7.  Hybrid chitosan-lipid nanoparticles of green tea extract as natural anti-cellulite agent with superior in vivo potency: full synthesis and analysis.

Authors:  Sara A Abosabaa; Mona G Arafa; Aliaa Nabil ElMeshad
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.